Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Medtronic
Dow
Express Scripts
McKesson

Last Updated: May 24, 2022

BUTALBITAL AND ACETAMINOPHEN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Butalbital And Acetaminophen, and what generic alternatives are available?

Butalbital And Acetaminophen is a drug marketed by Granules, Mayne Pharma Inc, Alvogen, Halsey, Larken Labs Inc, Lgm Pharma, Mikart, and Watson Labs. and is included in nine NDAs.

The generic ingredient in BUTALBITAL AND ACETAMINOPHEN is acetaminophen; butalbital. There are sixty-six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital profile page.

Drug patent expirations by year for BUTALBITAL AND ACETAMINOPHEN
Recent Clinical Trials for BUTALBITAL AND ACETAMINOPHEN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Federal University of São PauloPhase 4
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4
GlaxoSmithKlinePhase 3

See all BUTALBITAL AND ACETAMINOPHEN clinical trials

US Patents and Regulatory Information for BUTALBITAL AND ACETAMINOPHEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Granules BUTALBITAL AND ACETAMINOPHEN acetaminophen; butalbital CAPSULE;ORAL 213115-001 Nov 22, 2019 AA RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Lgm Pharma BUTALBITAL AND ACETAMINOPHEN acetaminophen; butalbital TABLET;ORAL 090956-001 Aug 23, 2011 AA RX No Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Alvogen BUTALBITAL AND ACETAMINOPHEN acetaminophen; butalbital TABLET;ORAL 205120-001 Oct 30, 2015 AA RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Mikart BUTALBITAL AND ACETAMINOPHEN acetaminophen; butalbital TABLET;ORAL 207386-001 Nov 15, 2016 AA RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Mayne Pharma Inc BUTALBITAL AND ACETAMINOPHEN acetaminophen; butalbital CAPSULE;ORAL 207313-001 Dec 27, 2017 AA RX No Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Alvogen BUTALBITAL AND ACETAMINOPHEN acetaminophen; butalbital TABLET;ORAL 207635-001 Jun 5, 2017 AA RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Larken Labs Inc BUTALBITAL AND ACETAMINOPHEN acetaminophen; butalbital TABLET;ORAL 203484-002 Dec 4, 2015 AA RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
AstraZeneca
Colorcon
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.